reviewTop 1% cited
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
Molecular Psychiatry · 2004 · Vol. 10(1) · pp. 79–104
Seiya Miyamoto✉(St. Marianna University School of Medicine)G E Duncan(University of North Carolina at Chapel Hill)Brian P. Marx(Duke University)J.A. Lieberman(University of North Carolina at Chapel Hill)
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorReceptor Mechanisms and SignalingAntipsychoticSchizophrenia (object-oriented programming)Context (archaeology)MedicinePsychiatryDrugPsychosisPsychologyPharmacologyNeuroscience
MeSH terms
Behavioral SymptomsHumansSchizophreniaAntipsychotic AgentsDrug DesignDopamine AgentsReceptors, Dopamine D2Receptors, GlutamateExcitatory Amino Acid Agents
Citations
974
FWCI
17.34
field-weighted impact
References
396
Percentile
100%
vs. same field & year
Citations per year
Cited by
Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future
Schizophrenia Research · 2010 · 381 citations
References
Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex
Journal of Neuroscience · 1997 · 1,794 citations
Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors
Journal of Pharmacology and Experimental Therapeutics · 2002 · 915 citations
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Archives of General Psychiatry · 1987 · 3,727 citations
Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans
Archives of General Psychiatry · 1994 · 3,315 citations
NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers
Neuropsychopharmacology · 1996 · 694 citations
Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials
Schizophrenia Research · 2003 · 469 citations
Elevated endogenous cannabinoids in schizophrenia
Neuroreport · 1999 · 432 citations
Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys
Psychopharmacology · 1994 · 577 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.